Manufacturing and Production
Lilly’s Olumiant impresses in twin Phase 3 atopic dermatitis trials
February 5, 2019 Manufacturing and Production, Research and Development Eli Lilly, Olumiant, atopic dermatitis, pharma
AstraZeneca scores accelerated approval in US and Europe for respiratory syncytial virus drug
February 5, 2019 Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, EMA, FDA, MEDI8897, pharma, respiratory syncytial virus
More than 200 Xanax-related deaths in UK since 2015
February 5, 2019 Manufacturing and Production Pfizer, UK, benzodiazepines, health, public health, xanax
Reformulated OxyContin led to spike in Hepatitis C infections
February 5, 2019 Manufacturing and Production OxyContin, USA, hepatitis C, heroin, infectious diseases, opioids
Sanders calls on Catalyst pharma to justify $375,000 price tag for rare disease drug which was once free
February 5, 2019 Manufacturing and Production Catalyst Pharmaceuticals, Jacobus Pharmaceuticals, Sanders, USA, pharma, pricing
Alexander Hardy returns to Genentech as new CEO
February 4, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genentech, appointment, pharma
Counterfeit drugs – countering the lies
February 4, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Counterfeit drugs, IP, counterfeit medicines, falsified medicines, intellectual property, law, legal, patent
Top Ten most popular articles on Pharmafile.com this week!
February 1, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, England, NHS, Purdue, Vertex, insys, israel, oncology, pharma, top 10
Repurposed drugs: The Supreme Court deals a blow to patentees
January 31, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Supreme Court, drug repurposing, feature, patents, pharma
Richard Ridinger resigns from CEO position at Lonza causing shares to plummet
January 30, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Lonza, Marc Funk, Richard Ridinger, Switzerland
Read Pharmafocus January/February 2019 edition online now!
January 30, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Cancer, Counterfeit drugs, NHS, Pharmafocus, WHO, brexit, pharma, vaccines
Opioid drugmaker Purdue Pharma inks deal with Alivio over non-opioid inflammation drug
January 29, 2019 Manufacturing and Production Alivio, Purdue Pharma, health, inflammation, opioids
Imbruvica combo scores expanded FDA approval in most common adult form of leukaemia
January 29, 2019 Manufacturing and Production, Sales and Marketing AbbVie, Cancer, Janssen, imbruvica, leukaemia, pharma
Precision cancer treatment for dogs moves towards human testing
January 29, 2019 Manufacturing and Production CAR-T therapy, Cancer, Precision Medicine, car t therapy, dogs, t cells, t-cells
Destiny Pharma secures £1.6m grant to fight ‘superbugs’ and antimicrobial resistance
January 29, 2019 Manufacturing and Production, Research and Development Destiny Pharma, antimicrobial resistance, pharma
Latest content
ESTEVE CDMO adds $17.5m to Illinois expansion
Brenntag and dsm-firmenich expand biopharma vitamin partnership
